CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dr. Lal PathLabs Ltd Company Snapshot
Dr. Lal PathLabs Ltd operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dr. Lal PathLabs Ltd with three other pharmaceutical manufacturers in Asia: Thyrocare Technologies Ltd (2018 sales of 3.56 billion Indian Rupees [US$49.17 million] ), Ina Research Incorporation of Japan (2.43 billion Japanese Yen [US$21.32 million] ), and Medical & Biological Laboratories Company Limited which is also based in Japan (7.07 billion Japanese Yen [US$62.16 million] of which 99% was Reagent business).

Sales Analysis. Dr. Lal PathLabs Ltd reported sales of 10.57 billion Indian Rupees (US$145.85 million) for the fiscal year ending March of 2018. This represents an increase of 15.8% versus 2017, when the company's sales were 9.12 billion Indian Rupees. Sales at Dr. Lal PathLabs Ltd have increased during each of the previous five years (and since 2013, sales have increased a total of 134%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dr. Lal PathLabs Ltd
  Stock Performance Chart for Dr. Lal PathLabs Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 861.45
(Figures in Indian Rupees)
1 Week -2.9%   13 Weeks -10.9%  
4 Weeks -7.0%   52 Weeks 1.1%  
 
Dr. Lal PathLabs Ltd Key Data:
  Ticker: LALPATHLAB Country: India
  Exchanges: BOM Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2018 Sales 10,569,180,000
(Year Ending Jan 2019).
Employees: 4,316
  Currency: Indian Rupees Market Cap: 71,758,785,000
  Fiscal Yr Ends: March Shares Outstanding: 83,300,000
  Share Type: Ordinary Closely Held Shares: 59,747,184
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.